Clinical Trial Update: Side Effects of 4 Times Bone Marrow Mono Nuclear Transplantation in Patients With Ischemic Lower Limb [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update describing side effects observed after fourfold dosing of bone marrow mononuclear cell transplantation in patients with ischemic lower li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Ulcer

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)

Snippet

Sponsor: Royan Institute | Conditions: Ischemic Ulcer | Phase 1, Phase 2 | Status: COMPLETED